← Eichor
Study identifier: NCT06701214 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Condition: Clonal Hematopoiesis  ·  Sponsor: Vanderbilt-Ingram Cancer Center

PhaseN/A
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.

This description comes directly from the study's public registry record.

Talk to the study team

Vanderbilt-Ingram Services for Timely Access  ·  800-811-8480  ·  cip@vumc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Vanderbilt University/Ingram Cancer CenterNashville, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06701214